- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/00 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
Patent holdings for IPC class C07D 231/00
Total number of patents in this class: 138
10-year publication summary
|
6
|
5
|
8
|
7
|
8
|
6
|
5
|
3
|
1
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Wella Operations US LLC | 834 |
7 |
| The Johns Hopkins University | 5972 |
6 |
| Novartis AG | 10162 |
5 |
| Boehringer Ingelheim International GmbH | 4482 |
4 |
| Merck Sharp & Dohme LLC | 3715 |
4 |
| Merck Sharp & Dohme Corp. | 2183 |
3 |
| The Wistar Institute of Anatomy and Biology | 490 |
3 |
| Bristol-myers Squibb Company | 4758 |
2 |
| Hoffmann-La Roche Inc. | 3885 |
2 |
| Novartis Pharma AG | 288 |
2 |
| BASF SE | 21337 |
2 |
| Janssen Pharmaceutica N.V. | 3110 |
2 |
| Pfizer Inc. | 3435 |
2 |
| Bayer Intellectual Property GmbH | 2336 |
2 |
| Bayer Cropscience AG | 1811 |
2 |
| Bayer Animal Health GmbH | 167 |
2 |
| Mayo Foundation for Medical Education and Research | 3443 |
2 |
| FMC Corporation | 817 |
2 |
| Lycera Corporation | 31 |
2 |
| PGI Drug Discovery LLC | 32 |
2 |
| Other owners | 80 |